Share

Oliver Medvedik, co-founder of the Life Extension Advocacy Foundation and the Lifespan.io crowdfunding platform, discusses the CRISPR/Cas9 gene editing system in depth and highlights how it may be used to help overcome the diseases and disabilities of aging.

He also gives an overview of other promising areas in aging research, such as senescent cell-clearing drugs (senolytics) and “augmentive” compounds that may help restore the body to youthful functionality.

This presentation is part of the Designing New Advances conference held by the Institute of Exponential Sciences in the Netherlands, which is organized by Demian Hoed and Lotte Van Norte.

CategoryAdvocacy, News
About the author

Dr. Oliver Medvedik

Oliver Medvedik, Co-founder of Genspace citizen science laboratory in Brooklyn NY, earned his Ph.D. at Harvard Medical School in the Biomedical and Biological Sciences program. As part of his doctoral work he has used single-celled budding yeast as a model system to map the genetic pathways that underlie the processes of aging in more complex organisms, such as humans. Prior to arriving in Boston for his doctoral studies, he has lived most of his life in New York City. He obtained his bachelor’s degree in biology from Hunter College, City University of New York. Since graduating from Harvard, he has worked as a biotechnology consultant, taught molecular biology to numerous undergraduates at Harvard University and mentored two of Harvard’s teams for the international genetically engineered machines competition (IGEM) held annually at M.I.T.

© 2020 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

       Powered by MMD